-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Therapies under investigation for treating Parkinsons disease psychosis
Niem Tu Huynh & Philippe Huot
Clinical Trail Outcomes: Clinical Investigation
-
Therapies under investigation for treating Parkinsons disease psychosis
Niem Tu Huynh & Philippe Huot
Clinical Trail Outcomes: Clinical Investigation
-
Therapies under investigation for treating Parkinsons disease psychosis
Niem Tu Huynh & Philippe Huot
Clinical Trail Outcomes: Clinical Investigation
-
Therapies under investigation for treating Parkinsons disease psychosis
Niem Tu Huynh & Philippe Huot
Clinical Trail Outcomes: Clinical Investigation
-
Therapies under investigation for treating Parkinsons disease psychosis
Niem Tu Huynh & Philippe Huot
Clinical Trail Outcomes: Clinical Investigation
-
Therapies under investigation for treating Parkinsons disease psychosis
Niem Tu Huynh & Philippe Huot
Clinical Trail Outcomes: Clinical Investigation
-
Therapies under investigation for treating Parkinsons disease psychosis
Niem Tu Huynh & Philippe Huot
Clinical Trail Outcomes: Clinical Investigation
-
Therapies under investigation for treating Parkinsons disease psychosis
Niem Tu Huynh & Philippe Huot
Clinical Trail Outcomes: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Adult ADHD: an area lacking in clinical research?
Josep Antoni, Ramos-Quiroga & Miren Ochoa Sagues
Editorial: Clinical Investigation
-
Adult ADHD: an area lacking in clinical research?
Josep Antoni, Ramos-Quiroga & Miren Ochoa Sagues
Editorial: Clinical Investigation
-
Adult ADHD: an area lacking in clinical research?
Josep Antoni, Ramos-Quiroga & Miren Ochoa Sagues
Editorial: Clinical Investigation
-
Adult ADHD: an area lacking in clinical research?
Josep Antoni, Ramos-Quiroga & Miren Ochoa Sagues
Editorial: Clinical Investigation
-
Adult ADHD: an area lacking in clinical research?
Josep Antoni, Ramos-Quiroga & Miren Ochoa Sagues
Editorial: Clinical Investigation
-
Adult ADHD: an area lacking in clinical research?
Josep Antoni, Ramos-Quiroga & Miren Ochoa Sagues
Editorial: Clinical Investigation
-
Adult ADHD: an area lacking in clinical research?
Josep Antoni, Ramos-Quiroga & Miren Ochoa Sagues
Editorial: Clinical Investigation
-
Adult ADHD: an area lacking in clinical research?
Josep Antoni, Ramos-Quiroga & Miren Ochoa Sagues
Editorial: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Medical therapy for atherosclerotic renal artery stenosis
Pascal Meier
Editorial: Clinical Investigation
-
Medical therapy for atherosclerotic renal artery stenosis
Pascal Meier
Editorial: Clinical Investigation
-
Medical therapy for atherosclerotic renal artery stenosis
Pascal Meier
Editorial: Clinical Investigation
-
Medical therapy for atherosclerotic renal artery stenosis
Pascal Meier
Editorial: Clinical Investigation
-
Medical therapy for atherosclerotic renal artery stenosis
Pascal Meier
Editorial: Clinical Investigation
-
Medical therapy for atherosclerotic renal artery stenosis
Pascal Meier
Editorial: Clinical Investigation
-
Medical therapy for atherosclerotic renal artery stenosis
Pascal Meier
Editorial: Clinical Investigation
-
Medical therapy for atherosclerotic renal artery stenosis
Pascal Meier
Editorial: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for anti-atherosclerotic drugs
Therese M Heinonen, Donald M Black
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for anti-atherosclerotic drugs
Therese M Heinonen, Donald M Black
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for anti-atherosclerotic drugs
Therese M Heinonen, Donald M Black
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for anti-atherosclerotic drugs
Therese M Heinonen, Donald M Black
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for anti-atherosclerotic drugs
Therese M Heinonen, Donald M Black
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for anti-atherosclerotic drugs
Therese M Heinonen, Donald M Black
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for anti-atherosclerotic drugs
Therese M Heinonen, Donald M Black
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for anti-atherosclerotic drugs
Therese M Heinonen, Donald M Black
Review Article: Clinical Investigation